Doravirine (CED0007885)

Record Information
Version1.0
Creation Date2026-04-05 13:49:52 UTC
Update Date2026-08-19 18:16:43 UTC
SynCED IDCED0007885
Secondary Accession Numbers
  • CHEM103274
Identification
Common NameDoravirine
ClassSmall Molecule
Description
Doravirine is an organic compound with the formula C17H11ClF3N5O3 and an average molecular weight of 425.75 g/mol. Doravirine belongs to the ethers, a subclass of organooxygen compounds within the organic compounds. This compound is recorded as being released from healthcare, pharmaceuticals, and veterinary products specifically as an antiviral, with oral exposure being the recorded route. In terms of biological activity, doravirine acts as an inhibitor of two protein targets: the Gag-Pol polyprotein (gag-pol) and Reverse transcriptase/RNaseH (pol).
Contaminant TypeNot Available
Chemical Structure
SynonymsNot Available
Chemical FormulaC17H11ClF3N5O3
Average Molecular Mass425.750 g/mol
Monoisotopic Mass425.050 g/mol
CAS Registry Number1338225-97-0
IUPAC NameNot Available
Traditional NameNot Available
SMILESCN1C(=O)NN=C1CN1C=CC(=C(OC2=CC(Cl)=CC(=C2)C#N)C1=O)C(F)(F)F
InChI IdentifierInChI=1S/C17H11ClF3N5O3/c1-25-13(23-24-16(25)28)8-26-3-2-12(17(19,20)21)14(15(26)27)29-11-5-9(7-22)4-10(18)6-11/h2-6H,8H2,1H3,(H,24,28)
InChI KeyZIAOVIPSKUPPQW-UHFFFAOYSA-N
Chemical Taxonomy
ClassificationNot classified
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological Roles
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted PropertiesNot Available
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyDeposition DateView
Predicted GC-MSPredicted GC-MS Spectrumsplash10-0wmi-1539200000-bc5dd78c5dc9b16615e9Not AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted GC-MSPredicted GC-MS SpectrumNot AvailableNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-004i-1102900000-85159263a4e1f67db4fdNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-02ta-0219100000-d6ddc6a4128222a041d1Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-053i-8928000000-39d7c30b07d1de9e85d9Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-014i-2009000000-f1affba5de17dc10816dNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-014i-1109100000-d953f236c324da9b5329Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0zfu-4912000000-7eac1fbcbbae47e7fb50Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-004i-0000900000-c2c10af104f690d1e43cNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-004r-0109400000-f42cb9021f31cd5b24abNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0f9i-3819000000-209cda74b17fdb5cce5fNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-00di-0401900000-17fb69f803a4a3e2aa13Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0udi-5809000000-c18aeb067425b7980067Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-001i-9001000000-7e76979acba163304f23Not AvailableView Spectrum
Toxicity Profile
Toxicity Values
Toxicity ValueOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalToxicity RatingReference
5547.0 Log mg/kg [3100:9900]RatLD50oralpredictedNot AvailableNot Available
Toxicity / Toxin ClassNot Available
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Health Effects
Health EffectRelationshipDirectionDescriptionReference
human immunodeficiency virus infectious diseaseNot AvailableNot AvailableNot AvailablePMC10247436
Exposure Sources
Source IDSourceSectorReference
CEDs000351Antivirals?Antivirals are synthetic chemicals designed to inhibit the replication of viruses and are widely used in the treatment of viral infections in humans and animals.Healthcare, pharmaceuticals & veterinary productsNot Available
CEDs000518Electrically Stimulated Smoking Devices?Electrically stimulated smoking devices, commonly known as e-cigarettes or vape pens, utilize electrical components to heat a liquid solution, often containing nicotine, flavorings, and other additives, to produce an aerosol for inhalation.Electrical & Electronic EquipmentPubChem
CEDs000559Non Electric Simulated Smoking Devices?Non-electric simulated smoking devices, often designed to mimic the experience of smoking without combustion, can be sources of synthetic chemical contamination due to the materials and chemicals used in their construction and operation.Household cleaning & consumer productsPubChem
CEDs000606Plant Growth Regulators?Plant Growth Regulators (PGRs) are synthetic chemicals designed to influence the growth and development of plants.Agriculture & land managementPubChem
CEDs000671Airplanes And Helicopters?Airplanes and helicopters are significant sources of synthetic chemical contamination primarily through the use of aviation fuels, lubricants, and de-icing agents.Aviation & AerospacePubChem
CEDs000696Nanotechnology?Nanotechnology involves the manipulation of materials at the molecular or atomic level, typically within the range of 1 to 100 nanometers.Industrial manufacturing & chemical processingPubChem
Pathways
2 pathwaysPathway Source: PathBank
Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Cytochrome P450 2D6 structureClick to view 3D structureCytochrome P450 2D6P10635HumansKnownNot Available
Cytochrome P450 2C9 structureClick to view 3D structureCytochrome P450 2C9P11712HumansPredicted (SEA)
Prediction Confidence Score
0.252
Applicability Domain
0.345
Statistical Significance
0.4845
Supporting Reference Compounds
1245
E-value
3771.56
Eukaryotic translation initiation factor 4E-binding protein 1 structureClick to view 3D structureEukaryotic translation initiation factor 4E-binding protein 1Q13541HumansPredicted (SEA)
Prediction Confidence Score
0.25
Applicability Domain
0.25 Low confidence
Statistical Significance
0.0021
Supporting Reference Compounds
1
E-value
16.7376
Cytochrome P450 3A4 structureClick to view 3D structureCytochrome P450 3A4P08684HumansPredicted (SEA)
Prediction Confidence Score
0.233
Applicability Domain
0.264 Low confidence
Statistical Significance
0.7453
Supporting Reference Compounds
1538
E-value
5801.87
Vascular endothelial growth factor receptor 2 structureClick to view 3D structureVascular endothelial growth factor receptor 2P35968HumansPredicted (SEA)
Prediction Confidence Score
0.233
Applicability Domain
0.245 Low confidence
Statistical Significance
0.6171
Supporting Reference Compounds
1660
E-value
4804.46
Fibroblast growth factor receptor 1 structureClick to view 3D structureFibroblast growth factor receptor 1P11362HumansPredicted (SEA)
Prediction Confidence Score
0.232
Applicability Domain
0.245 Low confidence
Statistical Significance
0.5399
Supporting Reference Compounds
1010
E-value
4203.16
Reverse transcriptase/RNaseH structureClick to view 3D structureReverse transcriptase/RNaseHQ72547Human immunodeficiency virus 1Predicted (SEA)
Prediction Confidence Score
0.23
Applicability Domain
0.345
Statistical Significance
0.0262
Supporting Reference Compounds
79
E-value
204.121
Aurora kinase B structureClick to view 3D structureAurora kinase BQ96GD4HumansPredicted (SEA)
Prediction Confidence Score
0.229
Applicability Domain
0.245 Low confidence
Statistical Significance
0.583
Supporting Reference Compounds
1017
E-value
4538.45
Insulin-like growth factor 1 receptor structureClick to view 3D structureInsulin-like growth factor 1 receptorP08069HumansPredicted (SEA)
Prediction Confidence Score
0.228
Applicability Domain
0.245 Low confidence
Statistical Significance
0.534
Supporting Reference Compounds
785
E-value
4157.15
Click to view 3D structureTransient receptor potential cation channel subfamily C member 5Q8VD38Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.227
Applicability Domain
0.227 Low confidence
Statistical Significance
0.0047
Supporting Reference Compounds
1
E-value
36.9784
Cytochrome P450 2D6 structureClick to view 3D structureCytochrome P450 2D6P10635HumansPredicted (SEA)
Prediction Confidence Score
0.227
Applicability Domain
0.264 Low confidence
Statistical Significance
0.7263
Supporting Reference Compounds
1130
E-value
5654.58
Short transient receptor potential channel 5 structureClick to view 3D structureShort transient receptor potential channel 5Q9UL62HumansPredicted (SEA)
Prediction Confidence Score
0.227
Applicability Domain
0.24 Low confidence
Statistical Significance
0.0072
Supporting Reference Compounds
21
E-value
55.8957
Hepatocyte growth factor receptor structureClick to view 3D structureHepatocyte growth factor receptorP08581HumansPredicted (SEA)
Prediction Confidence Score
0.226
Applicability Domain
0.245 Low confidence
Statistical Significance
0.5923
Supporting Reference Compounds
934
E-value
4611.4
Short transient receptor potential channel 4 structureClick to view 3D structureShort transient receptor potential channel 4Q9UBN4HumansPredicted (SEA)
Prediction Confidence Score
0.226
Applicability Domain
0.24 Low confidence
Statistical Significance
2.00e-04
Supporting Reference Compounds
4
E-value
1.55698
Receptor-type tyrosine-protein kinase FLT3 structureClick to view 3D structureReceptor-type tyrosine-protein kinase FLT3P36888HumansPredicted (SEA)
Prediction Confidence Score
0.226
Applicability Domain
0.245 Low confidence
Statistical Significance
0.6489
Supporting Reference Compounds
1274
E-value
5051.64
Tyrosine-protein kinase Lck structureClick to view 3D structureTyrosine-protein kinase LckP06239HumansPredicted (SEA)
Prediction Confidence Score
0.226
Applicability Domain
0.245 Low confidence
Statistical Significance
0.6556
Supporting Reference Compounds
1130
E-value
5103.72
Mitogen-activated protein kinase 8 structureClick to view 3D structureMitogen-activated protein kinase 8P45983HumansPredicted (SEA)
Prediction Confidence Score
0.225
Applicability Domain
0.245 Low confidence
Statistical Significance
0.5874
Supporting Reference Compounds
782
E-value
4572.71
Glycogen synthase kinase-3 beta structureClick to view 3D structureGlycogen synthase kinase-3 betaP49841HumansPredicted (SEA)
Prediction Confidence Score
0.225
Applicability Domain
0.245 Low confidence
Statistical Significance
0.6597
Supporting Reference Compounds
1157
E-value
5136.02
Transient receptor potential cation channel subfamily V member 4 structureClick to view 3D structureTransient receptor potential cation channel subfamily V member 4Q9HBA0HumansPredicted (SEA)
Prediction Confidence Score
0.225
Applicability Domain
0.247 Low confidence
Statistical Significance
0.0344
Supporting Reference Compounds
32
E-value
267.568
Voltage-gated inwardly rectifying potassium channel KCNH2 structureClick to view 3D structureVoltage-gated inwardly rectifying potassium channel KCNH2Q12809HumansPredicted (SEA)
Prediction Confidence Score
0.225
Applicability Domain
0.228 Low confidence
Statistical Significance
0.8131
Supporting Reference Compounds
1498
E-value
6330.0
Cannabinoid receptor 1 structureClick to view 3D structureCannabinoid receptor 1P21554HumansPredicted (SEA)
Prediction Confidence Score
0.224
Applicability Domain
0.247 Low confidence
Statistical Significance
0.2618
Supporting Reference Compounds
200
E-value
2038.09
Epidermal growth factor receptor structureClick to view 3D structureEpidermal growth factor receptorP00533HumansPredicted (SEA)
Prediction Confidence Score
0.224
Applicability Domain
0.245 Low confidence
Statistical Significance
0.6875
Supporting Reference Compounds
1301
E-value
5352.21
Serine/threonine-protein kinase PLK1 structureClick to view 3D structureSerine/threonine-protein kinase PLK1P53350HumansPredicted (SEA)
Prediction Confidence Score
0.223
Applicability Domain
0.245 Low confidence
Statistical Significance
0.5626
Supporting Reference Compounds
705
E-value
4379.8
Tyrosine-protein kinase SYK structureClick to view 3D structureTyrosine-protein kinase SYKP43405HumansPredicted (SEA)
Prediction Confidence Score
0.223
Applicability Domain
0.245 Low confidence
Statistical Significance
0.5379
Supporting Reference Compounds
625
E-value
4187.74
BDNF/NT-3 growth factors receptor structureClick to view 3D structureBDNF/NT-3 growth factors receptorQ16620HumansPredicted (SEA)
Prediction Confidence Score
0.222
Applicability Domain
0.245 Low confidence
Statistical Significance
0.5967
Supporting Reference Compounds
721
E-value
4645.65
Cyclin-dependent kinase 2 structureClick to view 3D structureCyclin-dependent kinase 2P24941HumansPredicted (SEA)
Prediction Confidence Score
0.222
Applicability Domain
0.245 Low confidence
Statistical Significance
0.6483
Supporting Reference Compounds
1029
E-value
5046.96
Concentrations
Not Available
External Links
IdentifiersNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General ReferencesNot Available